v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Conversion of Legacy Blaize convertible notes
Net exercise of Legacy Blaize warrants
Common Stock Subject to Possible Redemption
Common Stock
Common Stock
Conversion of Legacy Blaize convertible notes
Common Stock
Net exercise of Legacy Blaize warrants
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of Legacy Blaize convertible notes
Additional Paid-in Capital
Net exercise of Legacy Blaize warrants
Accumulated Other Comprehensive Income
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024       0                
Beginning balance at Dec. 31, 2024       $ 0                
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Increase in redemption value       603                
Redemption of common stock subject to possible redemption       $ (33,157)                
Redemption of common stock subject to possible redemption (in shares)       (2,800,489)                
Lapse of redemption       $ (507)                
Lapse of redemption (in shares)       (53,753)                
Merger and PIPE financing       $ 33,061                
Merger and PIPE financing (in shares)       2,854,242                
Ending balance at Jun. 30, 2025       $ 0                
Ending balance (in shares) at Jun. 30, 2025       0                
Beginning balance (in shares) at Dec. 31, 2024         48,376,052              
Beginning balance at Dec. 31, 2024 $ (110,463)       $ 5     $ 318,783       $ (429,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of Legacy Blaize convertible notes, Net exercise of Legacy Blaize warrants and lapse of redemption 503 $ 314,334 $ 75,057     $ 3 $ 1 503 $ 314,331 $ 75,056    
Conversion of Legacy Blaize convertible notes, Net exercise of Legacy Blaize warrants and lapse of redemption (in shares)         53,753 31,433,259 7,505,657          
Merger and PIPE financing (in shares)         11,408,957              
Merger and PIPE financing (126,164)       $ 1     (126,165)        
Payment on shareholder note receivable 200             200        
Issuance of common stock to advisors (in shares)         104,255              
Issuance of common stock to advisors 300             300        
Issuance of common stock warrants to advisor 167             167        
Stock-based compensation 18,606             18,606        
Change in foreign currency translation adjustments, net 0                      
Net loss (177,350)                     (177,350)
Ending balance (in shares) at Jun. 30, 2025         98,881,933              
Ending balance at Jun. 30, 2025 (4,810)       $ 10     601,781       (606,601)
Beginning balance (in shares) at Mar. 31, 2025       2,854,242                
Beginning balance at Mar. 31, 2025       $ 33,061                
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Increase in redemption value       603                
Redemption of common stock subject to possible redemption       $ (33,157)                
Redemption of common stock subject to possible redemption (in shares)       (2,800,489)                
Lapse of redemption       $ (507)                
Lapse of redemption (in shares)       (53,753)                
Ending balance at Jun. 30, 2025       $ 0                
Ending balance (in shares) at Jun. 30, 2025       0                
Beginning balance (in shares) at Mar. 31, 2025         98,818,874              
Beginning balance at Mar. 31, 2025 16,710       $ 10     593,712       (577,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of Legacy Blaize convertible notes, Net exercise of Legacy Blaize warrants and lapse of redemption 503             503        
Conversion of Legacy Blaize convertible notes, Net exercise of Legacy Blaize warrants and lapse of redemption (in shares)         53,753              
Issuance of common stock to advisors (in shares)         9,306              
Stock-based compensation 7,566             7,566        
Change in foreign currency translation adjustments, net 0                      
Net loss (29,589)                     (29,589)
Ending balance (in shares) at Jun. 30, 2025         98,881,933              
Ending balance at Jun. 30, 2025 $ (4,810)       $ 10     601,781       (606,601)
Beginning balance (in shares) at Dec. 31, 2025 122,043,966       122,043,966              
Beginning balance at Dec. 31, 2025 $ 39,000       $ 12     675,143       (636,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of stock options (in shares) 730,683       730,683              
Exercise of stock options $ 447             447        
Releases of restricted stock units (in shares)         1,111,497              
Withholding taxes on release of restricted stock units (47)             (47)        
Withholding taxes on release of restricted stock units (in shares)         (26,989)              
Reclassification of earnout awards to liability $ (29)             (29)        
Issuance of common stock in public offering, net of expenses (in shares) 18,918,918       18,918,918              
Issuance of common stock in public offering, net of expenses $ 32,574       $ 2     32,572        
Release of related party liabilities - non-cash 4,180             4,180        
Stock-based compensation 17,637             17,637        
Change in foreign currency translation adjustments, net 490                   $ 490  
Net loss $ (51,462)                     (51,462)
Ending balance (in shares) at Jun. 30, 2026 142,778,075       142,778,075              
Ending balance at Jun. 30, 2026 $ 42,790       $ 14     729,903     490 (687,617)
Beginning balance (in shares) at Mar. 31, 2026         122,746,757              
Beginning balance at Mar. 31, 2026 25,437       $ 12     684,108     125 (658,808)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of stock options (in shares)         681,481              
Exercise of stock options 401             401        
Releases of restricted stock units (in shares)         457,908              
Withholding taxes on release of restricted stock units (47)             (47)        
Withholding taxes on release of restricted stock units (in shares)         (26,989)              
Issuance of common stock in public offering, net of expenses (in shares)         18,918,918              
Issuance of common stock in public offering, net of expenses 32,574       $ 2     32,572        
Release of related party liabilities - non-cash 4,180             4,180        
Stock-based compensation 8,689             8,689        
Change in foreign currency translation adjustments, net 365                   365  
Net loss $ (28,809)                     (28,809)
Ending balance (in shares) at Jun. 30, 2026 142,778,075       142,778,075              
Ending balance at Jun. 30, 2026 $ 42,790       $ 14     $ 729,903     $ 490 $ (687,617)